Scientists in a lab viewing a 3D model of Bas63 bacteriophage, illustrating breakthroughs in phage therapy research.
Bilde generert av AI

3D structure of Bas63 bacteriophage mapped, offering clues for phage therapy

Bilde generert av AI
Faktasjekket

A University of Otago–led team, with collaborators at the Okinawa Institute of Science and Technology, has resolved the 3D structure of Bas63, a bacteriophage that infects E. coli. Published in Science Advances (online on November 12, 2025; issue dated November 14, 2025), the work details rare tail features and could inform rational phage design for medical, agricultural, and industrial uses.

Researchers have produced an in‑depth structural map of the Escherichia phage JohannRWettstein (Bas63), illuminating how its tail apparatus engages bacteria and how related viruses may have evolved. The study appears in Science Advances (DOI: 10.1126/sciadv.adx0790) and lists authors from the University of Otago and the Okinawa Institute of Science and Technology (OIST). Publication records show an online release on November 12, 2025 and an issue date of November 14, 2025. (pubmed.ncbi.nlm.nih.gov)

Lead author Dr. James Hodgkinson‑Bean described bacteriophages as “extremely exciting” alternatives to antibiotics, noting that “bacteriophage viruses are non‑harmful to all multi‑cellular life and able to very selectively target and kill a target bacterium,” which is why they are increasingly studied for phage therapy against drug‑resistant infections. Those remarks were published by the University of Otago and carried by ScienceDaily. (otago.ac.nz)

Using cryo‑electron microscopy, the team reconstructed Bas63 at molecular scale, identifying rare whisker‑and‑collar connections between the head and tail, decoration proteins at hexamer centers on the capsid, and multiple, diverse tail fibers—features that help explain how the virus recognizes and attacks its bacterial host. The OIST news release and the paper’s abstract highlight these elements, including β‑tulip and Hoc‑like decoration proteins, as well as long tail fibers resembling those in phage T4. (oist.jp)

Senior author Associate Professor Mihnea Bostina said the “detailed blueprint of a bacteriophage” can advance rational design for applications ranging from treating infections to combating biofilms in food processing and water systems, a comment echoed in Otago’s newsroom announcement. The researchers also frame the work amid rising antibiotic resistance and threats to global food security from plant pathogens. (otago.ac.nz)

The authors further argue that structural comparisons reveal distant evolutionary links, including relationships between bacteriophages and herpes viruses that may trace back billions of years—a perspective Hodgkinson‑Bean articulated in the university release. The underlying journal article focuses on structural conservation within the Felixounavirus genus and does not date those links, so the time‑scale characterization is presented here as the researchers’ interpretation. (otago.ac.nz)

This is the group’s second full phage structure in 2025: in April, members of the same Otago–OIST team reported the atomic‑level architecture of the potato‑pathogen‑targeting phage φTE in Nature Communications, work they say provides a template for designing biocontrol agents in agriculture. (pmc.ncbi.nlm.nih.gov)

Hva folk sier

Discussions on X about the 3D structure mapping of Bas63 bacteriophage are predominantly positive, emphasizing its potential to advance phage therapy against antibiotic-resistant bacteria. Researchers and science accounts highlight evolutionary insights and applications in medicine, agriculture, and industry. Shares from academic labs and enthusiasts express excitement over the structural details revealed by cryo-EM. No negative or skeptical sentiments were identified in recent posts.

Relaterte artikler

Microscopic view of bacterial defense mechanism using viral DNA remnants, with enzyme flipping genome to produce antiviral proteins.
Bilde generert av AI

Ancient viral remnants in bacteria point to new antiviral strategies

Rapportert av AI Bilde generert av AI Faktasjekket

Penn State researchers report a bacterial defense that repurposes dormant viral DNA: a recombinase enzyme called PinQ flips a stretch of genome to produce protective proteins that block infection, work described in Nucleic Acids Research.

Researchers from New England Biolabs and Yale University have developed the first fully synthetic system for engineering bacteriophages targeting Pseudomonas aeruginosa, a major antibiotic-resistant bacterium. Published in PNAS, the method uses digital DNA sequences to build viruses from scratch, bypassing traditional challenges in phage modification. This innovation aims to accelerate therapies against global antibiotic resistance threats.

Rapportert av AI Faktasjekket

Scientists at the University of Queensland have captured the first near‑atomic, high‑resolution 3D images of the yellow fever virus, detailing how the surface of the long‑used vaccine strain differs from virulent, disease‑causing strains. The work sheds light on how the virus is recognised by the immune system and could support improved vaccines for yellow fever and related mosquito‑borne diseases.

Researchers using artificial intelligence have identified a surface protein on the monkeypox virus that provokes strong neutralizing antibodies in mice. The protein, called OPG153, could form the basis of simpler vaccines and antibody therapies against mpox and may also inform future smallpox countermeasures, according to a study in Science Translational Medicine.

Rapportert av AI Faktasjekket

A Northwestern University team reports that redesigning the chemotherapy drug 5‑fluorouracil as a spherical nucleic acid markedly increased its cancer‑cell uptake and efficacy in acute myeloid leukemia models, with no observable side effects, according to a study published October 29 in ACS Nano.

Researchers have identified migrions, virus-like structures that enable faster and more severe viral spread by hijacking cell movement. These packages, formed in migrating cells infected with vesicular stomatitis virus, deliver multiple viral genomes simultaneously to new cells. The discovery challenges traditional models of infection and highlights increased disease potential in animal tests.

Rapportert av AI Faktasjekket

Researchers at Washington University School of Medicine in St. Louis, working with scientists at Northwestern University, have developed a noninvasive nasal nanotherapy that activates the immune system to attack aggressive brain tumors in mice. By delivering spherical nucleic acids that trigger the STING immune pathway directly from the nose to the brain, the approach eliminated glioblastoma tumors in mouse models when combined with drugs that boost T-cell activity, according to a study in the Proceedings of the National Academy of Sciences.

 

 

 

Dette nettstedet bruker informasjonskapsler

Vi bruker informasjonskapsler for analyse for å forbedre nettstedet vårt. Les vår personvernerklæring for mer informasjon.
Avvis